VITROLOGY Canadian Trademark Information

On Tuesday, December 11, 2012, a canadian trademark registration was filed for VITROLOGY by SGS Vitrology Limited *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1606161. The current status of this trademark filing is Registration published. The VITROLOGY trademark is filed in the description of Paper and printed articles, namely, newsletters and magazines, books, printed publications, printed reports, printed instructional and teaching materials, namely: books, manuals, reports, guides, presentations, articles, all in the field of biological material and substances and medical devices testing and analysis, and in the fields of virology and biosafety testing and analysis. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; patient monitoring services in the field of biological materials and biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. , Paper and printed articles, namely, newsletters and magazines, books, printed publications, printed reports, printed instructional and teaching materials, namely: books, manuals, reports, guides, presentations, articles, all in the field of biological material and substances and medical devices testing and analysis, and in the fields of virology and biosafety testing and analysis. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; patient monitoring services in the field of biological materials and biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; patient monitoring services in the field of biological materials and biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. , Paper and printed articles, namely, newsletters and magazines, books, printed publications, printed reports, printed instructional and teaching materials, namely: books, manuals, reports, guides, presentations, articles, all in the field of biological material and substances and medical devices testing and analysis, and in the fields of virology and biosafety testing and analysis. , Testing, analysis, research, study and structural characterization of biological materials, biological substances and medical devices; biochemistry testing services for use in the fields of biological materials and biological substances; industrial design services; creating projects, studies in the field of biological materials, biological substances and medical devices testing and analysis; environmental surveys; detection, identification and production of molecules for use in the production of medicines, medicines and vaccines for purposes of regulatory approvals; testing of monoclonal antibodies, proteins and recombinant proteins, virus and bacterial vaccines and cell therapies, gene therapy vectors and other biopharmaceutical products intended for human and veterinary administration; quality control of biological manufacturing testing services; virology services, namely: viral clearance chromatography services, in vitro adventitious virus assays and retrovirus assays and services, detection of viruses derived from animal products assays and services, screening virus vectors/vaccines for the presence of infectious contaminants assays and services, species-specific virus detection services by qPCR including but not restricted to human, simian, insect, murine, avian, chicken, duck, equine, bovine and porcine viruses; cell culture based assays and services; cell line characterization services including without limitation, validation and development of assays and methods and characterization of cell banks or batches or product derived from cell lines, of human or animal origin; services in the field of molecular biology, namely: validation and development of assays and testing services; Quantitative Polymerase Chain Reaction (qPCR) testing services for both preclinical and clinical requirements; patient monitoring services and biodistribution studies; identity, purity and stability assays and testing services, namely: microbial identity and genetic stability of cell lines; isoenzyme assay and DNA fingerprinting services; electron microscopy services, namely: transmission electron microscopy and virus particle detection and quantification; microbiology services namely: sterility culture-based assays and testing, mycoplasma culture-based assays and testing and mycobacteria culture-based assays and testing; biosafety services, namely: biosafety education, biosafety training, biosafety testing, biosafety certification, preparing, implementing and monitoring biosafety standards; consultancy services in the fields of biology, microbiology, biochemistry, virology, biosafety. .